Suppr超能文献

相似文献

1
Polyglutamine toxicity in non-neuronal cells.
Cell Res. 2010 Apr;20(4):400-7. doi: 10.1038/cr.2010.32. Epub 2010 Mar 16.
2
The Expanding Clinical Universe of Polyglutamine Disease.
Neuroscientist. 2019 Oct;25(5):512-520. doi: 10.1177/1073858418822993. Epub 2019 Jan 7.
3
[The advances in research on phosphorylation of polyglutamine disease].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):414-7.
4
Role of proteolysis in polyglutamine disorders.
J Neurosci Res. 2003 Nov 1;74(3):406-16. doi: 10.1002/jnr.10746.
5
Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
Neuropathology. 2006 Aug;26(4):346-51. doi: 10.1111/j.1440-1789.2006.00670.x.
6
Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors.
FEBS Lett. 2013 Jun 27;587(13):1997-2007. doi: 10.1016/j.febslet.2013.05.022. Epub 2013 May 15.
7
Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
Neuropathol Appl Neurobiol. 2004 Dec;30(6):665-75. doi: 10.1111/j.1365-2990.2004.00583.x.
8
Dynamic regulation of molecular chaperone gene expression in polyglutamine disease.
Biochem Biophys Res Commun. 2005 Sep 9;334(4):1074-84. doi: 10.1016/j.bbrc.2005.07.008.
9
Autophagy and Polyglutamine Disease.
Adv Exp Med Biol. 2020;1207:149-161. doi: 10.1007/978-981-15-4272-5_9.
10
Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1.
Nat Neurosci. 2000 Feb;3(2):103-4. doi: 10.1038/72042.

引用本文的文献

3
Systemic Symptoms in Huntington's Disease: A Comprehensive Review.
Mov Disord Clin Pract. 2024 May;11(5):453-464. doi: 10.1002/mdc3.14029. Epub 2024 Mar 26.
4
Large animal models for Huntington's disease research.
Zool Res. 2024 Mar 18;45(2):275-283. doi: 10.24272/j.issn.2095-8137.2023.199.
5
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications.
Pharmacol Rev. 2023 Mar;75(2):263-308. doi: 10.1124/pharmrev.122.000654. Epub 2022 Dec 22.
8
Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways.
React Oxyg Species (Apex). 2016 Sep;2(5):325-338. doi: 10.20455/ros.2016.859.
9
Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.
Nat Commun. 2017 Nov 30;8(1):1864. doi: 10.1038/s41467-017-01790-z.
10
Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity.
G3 (Bethesda). 2017 Jan 5;7(1):95-108. doi: 10.1534/g3.116.035675.

本文引用的文献

1
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22480-5. doi: 10.1073/pnas.0911503106. Epub 2009 Dec 11.
3
4
Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
Neuroimage. 2010 Feb 15;49(4):2995-3004. doi: 10.1016/j.neuroimage.2009.10.015. Epub 2009 Oct 19.
6
Beyond the brain: widespread pathology in Huntington's disease.
Lancet Neurol. 2009 Aug;8(8):765-74. doi: 10.1016/S1474-4422(09)70178-4.
8
Impaired PGC-1alpha function in muscle in Huntington's disease.
Hum Mol Genet. 2009 Aug 15;18(16):3048-65. doi: 10.1093/hmg/ddp243. Epub 2009 May 21.
9
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.
Hum Mol Genet. 2009 Mar 15;18(6):1006-16. doi: 10.1093/hmg/ddn428. Epub 2009 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验